...
首页> 外文期刊>Acta gastro-enterologica Belgica >Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population
【24h】

Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population

机译:系统综述和荟萃分析:血红蛋白(拟合)对症状和筛查人口筛选结直肠癌(FIT)的粪便免疫化学测试诊断准确性

获取原文
获取原文并翻译 | 示例
           

摘要

Background : Colorectal cancer (CRC) is one of the most common cancers worldwide. A non-invasive test, with high sensitivity and specificity is essential for early detection, improved outcome and avoidance of unnecessary invasive tests. This study aims to evaluate the accuracy of the faecal immunochemical testing for haemoglobin (FIT) in the detection of CRC, both in symptomatic and screening population and to summarise the available evidence to date. Methods : Search strategy was initially developed in MEDLINE and adapted for use in other databases. Studies were included if they had fulfilled the criteria. QUADAS-2 tool was used for quality assessment and data analysis performed using STATA 15 software. Results : A total of 17 out of 92 articles were included in the final analysis. Within the symptomatic group (n= 6755), the overall pooled sensitivity and specificity of FIT to detect CRC was 0.90 (95% CI 0.87-0.92) and 0.87 (95% CI 0.83-0.90) respectively. In the screening population (n=24197), the pooled sensitivity and specificity of FIT to detect CRC was 0.69 (95% CI 0.54-0.81) and 0.94 (95% CI 0.94-0.95) respectively. Most analytics were comparable with cut off less than 20μg/g feces providing optimal sensitivity and specificity for symptomatic and screening populations respectively. Conclusion : For the detection of CRC within the screening population, FIT has high specificity and sensitivity. In the symptomatic group, FIT’S high sensitivity (90%) supports its role as a triage test to guide the selection of patients who require urgent lower gastrointestinal tract evaluation.
机译:背景:结肠直肠癌(CRC)是全球最常见的癌症之一。具有高灵敏度和特异性的非侵入性测试对于早期检测,改善结果和避免不必要的侵入性测试至关重要。本研究旨在评估血红蛋白(拟合)在症状和筛选人口中检测CRC中粪便免疫化学测试的准确性,并总结了迄今为止的可用证据。方法:搜索策略最初在Medline中开发并适用于其他数据库。如果他们履行了标准,则包括研究。 Quadas-2工具用于使用Stata 15软件执行的质量评估和数据分析。结果:最终分析中共有92篇文章中的17个。在症状组(n = 6755)中,拟合的整体汇集敏感性和特异性检测CRc为0.90(95%CI 0.87-0.92)和0.87(95%CI 0.83-0.90)。在筛选群体(n = 24197)中,汇集敏感性和拟合特异性检测CRC为0.69(95%CI 0.54-0.81)和0.94(95%CI 0.94-0.95)。大多数分析与截止的剪切相当,分别为症状和筛查群体提供最佳敏感性和特异性。结论:为了检测筛查群体内的CRC,拟合具有高特异性和敏感性。在症状群体中,契合的高敏感性(90%)支持其作为分类测试的作用,以指导选择需要紧急降低胃肠道评估的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号